Advertisement



Drug Recalls

Last updated

Every drug recall in FDA enforcement reports from the last three years, plus older recalls that are still open. Filter by severity, status or medicine, and check the lot numbers on your package.

0 Class I (most serious) drug recalls reported in the last 30 days.

3,222 recalls

  • Class II Ongoing

    Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: Ast…

    Reason: Defective delivery system

    AsttraZeneca Pharmaceuticals LP · Albuterol Sulfate and Budesonide

    Lots, distribution and details
    Product
    Airsupra (albuterol and budesonide) inhalation aerosol, 90 mcg/80 mcg per inhalation, packaged in a) 120-inhalation canister (NDC 0310-9080-12) b) 28-inhalation canister (NDC 0310-9080-28), Rx only, Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850, By: AstraZeneca Dunkerque Production (AZDP), Dunkerque, France, Product of France, .
    Lots / codes
    Lot#: a) 6270044C00, 6270040D00, 6270034E00, Exp Date 10/2026; 6270053C00, 6270045C00, 6270047C00, 6270056C00, 6270052C00, 6270063E00 Exp 11/30/2026; 6270064C00, 6270071D00, 6270075D00, 6270075F00 Exp Date 12/31/2026; 6270107C00, Exp Date 9/30/2027; b) Lot 6270019E00, Exp Date 7/31/2025; 6270021D00, Exp 8/31/2025; 6270095C00, Exp 2/28/2026
    Distribution
    USA Nationwide
    Quantity
    a) 807,837 canisters; b) 235,698 canisters
    Recall started
    May 14, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0444-2025
  • Class II Ongoing

    Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA)…

    Reason: Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.

    Zydus Pharmaceuticals (USA) Inc · Esomeprazole Magnesium

    Lots, distribution and details
    Product
    Esomeprazole Magnesium for Delayed-Release Oral Suspension, 20 mg, 30-count single dose packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-848-94
    Lots / codes
    Lot #:M402147, Exp 10/2025; M311637, Exp 07/2025; M402495, Exp 02/2026; M407997, Exp 05/2026; M502246, Exp11/2026.
    Distribution
    Nationwide -in the USA
    Quantity
    22,152 30 sachets/carton
    Recall started
    May 13, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0443-2025
  • Class II Ongoing

    Esomeprazole Magnesium for Delayed-Release Oral Suspension, 40 mg, 30-count Single-Dose Packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA)…

    Reason: Failed Impurities/Degradation Specifications: Out-of-Specification test results obtained for any individual unknown degradation product during Related Compounds testing during long term stability.

    Zydus Pharmaceuticals (USA) Inc · Esomeprazole Magnesium

    Lots, distribution and details
    Product
    Esomeprazole Magnesium for Delayed-Release Oral Suspension, 40 mg, 30-count Single-Dose Packets per carton, Rx Only, Manufactured by: Zydus Lifesciences Ltd. Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-849-94
    Lots / codes
    Lot # M311638, Exp 07/2025, M400374, Exp 10/2025, M402496, Exp 02/2026, M407998, Exp 05/2026, M502247, Exp 11/2026, M414770, M414512, Exp 09/2026.
    Distribution
    Nationwide -in the USA
    Quantity
    30,674 30 sachets/carton
    Recall started
    May 13, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0442-2025
  • Class II Ongoing

    BD ChloraPrep Clear, 2% x/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), Patient Preoperative Skin Preparation, Sterile Solution, Applicator is sterile if package is intact, Flammable, External Use…

    Reason: Lack of Assurance of Sterility: The affected product may exhibit an open seal on the packaging of the applicator.

    CareFusion 213, LLC

    Lots, distribution and details
    Product
    BD ChloraPrep Clear, 2% x/v chlorhexidine gluconate (CHG) and 70% v/v isopropyl alcohol (IPA), Patient Preoperative Skin Preparation, Sterile Solution, Applicator is sterile if package is intact, Flammable, External Use Only, 1 mL Applicator per pouch, 60 Applicators per inner carton, CareFusion 213, LLC, El Paso, TX 79912, subsidiary of Becton, Dickinson and Co., Made in the USA, Catalog Number 930480, NDC 54365-400-31.
    Lots / codes
    Lot #s: 3354127 and 3350974, Exp Date: 12/31/2026
    Distribution
    Nationwide in the U.S.
    Quantity
    385,200 applicators
    Recall started
    May 15, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0441-2025
  • Class II Terminated

    Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 2.75 OZ (78g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-05

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot B0032, B0047, B0048, B0055, B0056, Exp Date: 07/31/2026; B0102, B0103, B0104, B0105, B0106, B0107, Exp Date: 09/30/2026
    Distribution
    DE and NC
    Quantity
    160,848 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0440-2025
  • Class II Terminated

    Nature Mint Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 1.5 OZ (43 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-04

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot B0004, Exp Date: 05/31/2026; B0060, Exp Date: 07/31/2026; Lot B0067, B0071, B0072, Exp Date: 08/31/2026; Lot B0107, B0108, Exp Date: 09/30/2026
    Distribution
    DE and NC
    Quantity
    150,768 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0439-2025
  • Class II Terminated

    Nature Mint Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 0.85 OZ (24 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-03

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot B0014, B0015, B0022, B0023, Exp Date: 05/31/2026; Lot B0024, B0025, B0026, B0027, B0033, B0034, B0035, B0039, B0040, B0041, B0045, Exp Date: 06/30/2026; Lot B0046, Exp Date: 07/31/2026
    Distribution
    DE and NC
    Quantity
    616,160 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0438-2025
  • Class II Terminated

    Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 6.4 OZ (181 grams) Box, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-07

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot B0067, Exp Date: 08/31/2026
    Distribution
    DE and NC
    Quantity
    4,176 boxes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0437-2025
  • Class II Terminated

    Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 0.6 OZ (17g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-02

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot B0015, B0016, Exp Date: 05/31/2026; Lot B0020, B0021, B0022, Exp Date: 06/30/2026; Lot B0056, B0057, Exp Date: 07/31/2026; Lot B0108, B0109, B0110, Exp Date: 09/30/2026
    Distribution
    DE and NC
    Quantity
    498,960 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0436-2025
  • Class II Terminated

    Nature Mint, Anticavity Fluoride Toothpaste, Sodium monofluorophosphate 0.76%, NET WT 4.6 OZ (130 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-131-06

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot B0027, B0031, Exp Date: 06/30/2026; Lot B0032, Exp Date: 07/31/2026
    Distribution
    DE and NC
    Quantity
    19,500 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0435-2025
  • Class II Terminated

    Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, NET WT 1.5 OZ (43 g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-04

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot B0013, Exp Date: 05/31/2026; Lot B0018, Exp Date: 06/30/2026; Lot B0053, B0054, Exp Date: 07/31/2026; Lot B0090, B0091, B0092, B0093, B0094, B0095, B0096, B0097, B0098, B0099, B0100, B0101, Exp Date: 09/30/2026
    Distribution
    DE and NC
    Quantity
    216,720 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0434-2025
  • Class II Terminated

    Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, NET WT 0.15 OZ (4.25 g) Sachets, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-01

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot B0010, B0017, Exp Date: 05/31/2026; Lot B0028, B0029, B0030, Exp Date: 06/30/2026; Lot B0052, Exp Date: 07/31/2026; Lot B0091, Exp Date: 09/30/2026
    Distribution
    DE and NC
    Quantity
    1,559,000 Sachets
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0433-2025
  • Class II Terminated

    Maximum Security, Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, NET WT 0.85 oz (24 g) Tube, Made in India, Dist. by Bob Barker Co. Inc. Fuquay-Varnia, NC 27526, NDC 53247-132-03

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot B0008, B0009, B0017, Exp Date: 05/31/2026; Lot B0042, B0043, B0044, Exp Date: 06/30/2026; Lot B0049, B0050, B0051, B0054, B0058, B0059, Exp Date: 07/31/2026; Lot B0061, B0062, B0063, B0064, B0065, B0068, B0069, Exp Date: 08/31/2026
    Distribution
    DE and NC
    Quantity
    615, 600 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0432-2025
  • Class II Terminated

    Maximum Security Anticavity Gel Toothpaste, Sodium Fluoride 0.22%, Fresh Mint Flavor, Net Wt 0.6 OZ (17 g) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-132-02

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot B0009, B0017, Exp Date: 05/31/2026; Lot B0018, B0019, B0036, B0037, B0038, Exp Date: 06/30/2026; Lot B0049, Exp Date: 07/31/2026; B0063, Exp Date: 08/31/2026
    Distribution
    DE and NC
    Quantity
    391,680 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0431-2025
  • Class II Terminated

    Cinnafresh anticavity gel toothpaste, sodium fluoride 0.22%, Bold Cinnamon Flavor, NET WT. 0.85 OZ (24 grams) Tube, Made in India, Dist. by Bob Barker Co. Inc., Fuquay-Varina, NC 27526, NDC 53247-133-01

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot B0011, B0012, Exp Date: 05/31/2026; Lot B0070, B0074, Exp Date: 08/31/2026; Lot B0075, B0077, B0078, B0079, B0080, B0081, B0082, B0083, B0084, B0085, Exp Date: 09/30/2026
    Distribution
    DE and NC
    Quantity
    383,904 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0430-2025
  • Class II Terminated

    Rapidol, Triple Antibiotic First Aid Ointment, Bacitracin Zinc/ Neomycin Sulfate/ Polymyxin B Sulfate, Net Wt 2 oz (56g) Tube, Distributed by: Pharmadel LLC, New Castle, DE, 19720, Made in India, NDC 55758-440-02, UPC 8…

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Product
    Rapidol, Triple Antibiotic First Aid Ointment, Bacitracin Zinc/ Neomycin Sulfate/ Polymyxin B Sulfate, Net Wt 2 oz (56g) Tube, Distributed by: Pharmadel LLC, New Castle, DE, 19720, Made in India, NDC 55758-440-02, UPC 8 10096 77162 9.
    Lots / codes
    Lot SP27A, Exp: 09/30/2026
    Distribution
    DE and NC
    Quantity
    9,336 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0429-2025
  • Class II Terminated

    Rapidol Maximum Strength, Hydrocortisone 1% Anti-Itch Cream, NET WT 2 oz (60g) Tube, Distributed by: Pharmadel LLC, New Castle, DE, 19720, NDC 55758-420-02, UPC 8 10096 77158 2.

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED · Hydrocortisone

    Lots, distribution and details
    Lots / codes
    Lot SP26A, Exp: 09/30/2026
    Distribution
    DE and NC
    Quantity
    10,000 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0428-2025
  • Class II Terminated

    Optim V, Anti-Itch Cream, Benzocaine 20% & Resorcinol 3% – External analgesic, Net Wt. Peso Neto 1 oz (28g) Tube, Distributed by: Pharmadel LLC, New Castle, DE 19720, Made in India, NDC 55758-300-01, UPC 8 59424 00420 6.

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot SP24A, Exp: 09/30/2026
    Distribution
    DE and NC
    Quantity
    6,372 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0427-2025
  • Class II Terminated

    KOFAL, Athletes, Penetrating Pain Relief, External Analgesic Ointment (methyl salicylate 10.5% – External Analgesic), 2 oz (60 g) Jar, Distributed by: Pharmadel LLC, New Castle, DE 19720, NDC 55758-109-02, UPC 8 99711 00…

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Product
    KOFAL, Athletes, Penetrating Pain Relief, External Analgesic Ointment (methyl salicylate 10.5% – External Analgesic), 2 oz (60 g) Jar, Distributed by: Pharmadel LLC, New Castle, DE 19720, NDC 55758-109-02, UPC 8 99711 00101 3.
    Lots / codes
    Lot SP30A, Exp Date: 09/30/2026
    Distribution
    DE and NC
    Quantity
    11,808 Jars
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0426-2025
  • Class II Terminated

    KOFAL Original, Penetrating Pain Relieving Ointment (methyl salicylate 12% – Topical Analgesic), 4 oz (113 g) Jar, Distributed by: Pharmadel LLC, Georgetown, DE 199747, NDC 55758-106-04, UPC 8 9971100128 0.

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lost SP21A, Exp Date: 03/31/2026
    Distribution
    DE and NC
    Quantity
    16,248 Jars
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0425-2025
  • Class II Terminated

    Kingskin, SacaCallos, 17% Salicylic acid, 0.5 fl oz (14.8mL) Bottle, Dist. by: Pharmadel LLC, New Castle, DE 19720, Made in India, NDC 55758-423-15, UPC 8 10096 77163 6.

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot SP28A, Exp Date: 09/30/2026
    Distribution
    DE and NC
    Quantity
    9,000 Bottles
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0424-2025
  • Class II Terminated

    CURA HONGOS, Antifungal Cream, Clotrimazole 1%, Net Wt/ Peso Neto 2 oz (56.7g) Tube, Distributed by: Pharmadel LLC, New Castle, DE 19720, Made in India, UPC 8 997110 011052.

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot SP23A, Exp Date: 03/31/2026
    Distribution
    DE and NC
    Quantity
    10,788 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0423-2025
  • Class II Terminated

    CURA HONGOS, Antifungal, 1% Clotrimazole, Topical Lotion, 0.76 fl oz (22.5 mL) Bottle, Dist by/por: Pharmadel LLC, New Castle, DE 19720, Made in India, NDC 55758-34-01, UPC 8 10096 77170 4.

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Lots / codes
    Lot SP31A, Exp Date: 09/30/2026
    Distribution
    DE and NC
    Quantity
    10,128 Bottles
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0422-2025
  • Class II Terminated

    Artridon Glucosamine (menthol 2% and Methyl Salicylate 15% – Topical Analgesic), for arthritis joint pain relief, 5 oz (142g) Tube, Dist by/por: Pharmadel LLC, New Castle, DE, 19720, Made in India, NDC 55758-030-05, UPC…

    Reason: CGMP Deviations

    KENIL HEALTHCARE PRIVATE LIMITED

    Lots, distribution and details
    Product
    Artridon Glucosamine (menthol 2% and Methyl Salicylate 15% – Topical Analgesic), for arthritis joint pain relief, 5 oz (142g) Tube, Dist by/por: Pharmadel LLC, New Castle, DE, 19720, Made in India, NDC 55758-030-05, UPC 8 10096 77151 3.
    Lots / codes
    Lot SP25A, Exp Date: 09/30/2026
    Distribution
    DE and NC
    Quantity
    9,984 Tubes
    Recall started
    April 24, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0421-2025
  • Class II Ongoing

    Testosterone Cypionate Injection, 200 mg/mL, CIII, Rx Only, 5 mL Sterile Multiple-Dose Vial, Compounded by: Empower Pharmacy, 7601 N Sam Houston Pkwy W Ste 100, Houston, TX, 77064, Phone: (877) 562-8577, Compounding Date…

    Reason: Lack of Assurance of Sterility

    Empower Clinic Services, LLC dba Empower Pharmacy · Testosterone Cypionate

    Lots, distribution and details
    Product
    Testosterone Cypionate Injection, 200 mg/mL, CIII, Rx Only, 5 mL Sterile Multiple-Dose Vial, Compounded by: Empower Pharmacy, 7601 N Sam Houston Pkwy W Ste 100, Houston, TX, 77064, Phone: (877) 562-8577, Compounding Date: 08/20/2024, Beyond Use by Date: 05/28/2025, Lot 202364.
    Lots / codes
    Lot #: 202364, Exp 5/28/2025
    Distribution
    USA Nationwide
    Quantity
    8,230 vials
    Recall started
    May 2, 2025 (Voluntary: Firm initiated)
    Severity
    Could cause temporary or medically reversible health problems; serious harm is unlikely.
    FDA recall number
    D-0420-2025

Have this medicine at home? Compare the lot number and expiry date on your package with the recall. Do not stop taking a prescribed medicine on your own — stopping suddenly can be riskier than the recalled lot. Your pharmacist can check it and usually swap it for an unaffected one.

What the recall classes mean

  • Class I Most serious: use could cause serious health problems or death.
  • Class II Could cause temporary or medically reversible health problems; serious harm is unlikely.
  • Class III Not likely to cause health problems — for example a labelling or packaging fault.

Source: FDA Enforcement Report, via openFDA. Updated here twice a day; last update November 2, 2026 14:41. openFDA data are not validated for clinical use — confirm with the FDA source or your pharmacist.

Advertisement